Search Results - "OTLEY, C. C"

Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management by Berg, Daniel, Otley, Clark C.

“…In the United States more than 100,000 people are living with solid organ transplants. The intense immunosuppressive regimens necessary for prolonged survival…”
Get full text

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system by Lemos, Bianca D., MD, Storer, Barry E., PhD, Iyer, Jayasri G., MD, Phillips, Jerri Linn, MA, CTR, Bichakjian, Christopher K., MD, Fang, L. Christine, MD, Johnson, Timothy M., MD, Liegeois-Kwon, Nanette J., MD, PhD, Otley, Clark C., MD, Paulson, Kelly G., PhD, Ross, Merrick I., MD, Yu, Siegrid S., MD, Zeitouni, Nathalie C., MD, Byrd, David R., MD, Sondak, Vernon K., MD, Gershenwald, Jeffrey E., MD, Sober, Arthur J., MD, Nghiem, Paul, MD, PhD

“…Background The management of Merkel cell carcinoma (MCC) has been complicated by a lack of detailed prognostic data and by the presence of conflicting staging…”
Get full text

Prognostic factors in Merkel cell carcinoma: Analysis of 240 cases by Tarantola, Tina I., MD, Vallow, Laura A., MD, Halyard, Michele Y., MD, Weenig, Roger H., MD, Warschaw, Karen E., MD, Grotz, Travis E., MD, Jakub, James W., MD, Roenigk, Randall K., MD, Brewer, Jerry D., MD, Weaver, Amy L., MS, Otley, Clark C., MD

“…Background Knowledge regarding behavior of and prognostic factors for Merkel cell carcinoma (MCC) is limited. Objective We sought to further understand the…”
Get full text

A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics by Farasat, Sharifeh, BS, Yu, Siegrid S., MD, Neel, Victor A., MD, PhD, Nehal, Kishwer S., MD, Lardaro, Thomas, BSc, Mihm, Martin C., MD, Byrd, David R., MD, Balch, Charles M., MD, Califano, Joseph A., MD, Chuang, Alice Y., MD, Sharfman, William H., MD, Shah, Jatin P., MD, PhD, Nghiem, Paul, MD, PhD, Otley, Clark C., MD, Tufaro, Anthony P., DDS, MD, Johnson, Timothy M., MD, Sober, Arthur J., MD, Liégeois, Nanette J., MD, PhD

“…Background The incidence of cutaneous squamous cell carcinoma (cSCC) is increasing. Although most patients achieve complete remission with surgical treatment,…”
Get full text

Adipocyte-Cancer Cell Interactions in the Bone Microenvironment by Otley, Meredith O. C., Sinal, Christopher J.

“…When compared to adipocytes in other anatomical sites, the interaction of bone marrow resident adipocytes with the other cells in their microenvironment is…”
Get full text

Antibiotic prophylaxis in dermatologic surgery: Advisory statement 2008 by Wright, Tina I., MD, Baddour, Larry M., MD, Berbari, Elie F., MD, Roenigk, Randall K., MD, Phillips, P. Kim, MD, Jacobs, M. Amanda, MD, Otley, Clark C., MD

“…Background Antibiotic prophylaxis is an important component of dermatologic surgery, and recommendations in this area should reflect the updated 2007…”
Get full text

Incidence and risk factors for skin cancer following lung transplantation by Rashtak, Shadi, MD, Dierkhising, Ross A., MS, Kremers, Walter K., PhD, Peters, Steve G., MD, Cassivi, Stephen D., MD, MSc, Otley, Clark C., MD

“…Background Relative to other solid-organ transplantations, limited studies characterize skin cancer among lung-transplant recipients. Objective We sought to…”
Get full text

Demographics and outcomes of microcystic adnexal carcinoma by King, Brian J., Tolkachjov, Stanislav N., Winchester, Daniel S., Baum, Christian L., Brewer, Jerry D., Arpey, Christopher J., Otley, Clark C., Roenigk, Randall K.

Get full text

Chronic Lymphocytic Leukemia Is Associated With Decreased Survival of Patients With Malignant Melanoma and Merkel Cell Carcinoma in a SEER Population-Based Study by BREWER, Jerry D, SHANAFELT, Tait D, OTLEY, Clark C, ROENIGK, Randall K, CERHAN, James R, KAY, Neil E, WEAVER, Amy L, CALL, Timothy G

“…To delineate outcomes of malignant melanoma (MM) and Merkel cell carcinoma (MCC) in patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma…”
Get full text

Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma by Iyer, Jayasri G., MD, Storer, Barry E., PhD, Paulson, Kelly G., MD, PhD, Lemos, Bianca, MD, Phillips, Jerri Linn, MA, CTR, Bichakjian, Christopher K., MD, Zeitouni, Nathalie, MD, Gershenwald, Jeffrey E., MD, Sondak, Vernon, MD, Otley, Clark C., MD, Yu, Siegrid S., MD, Johnson, Timothy M., MD, Liegeois, Nanette J., MD, Byrd, David, MD, Sober, Arthur, MD, Nghiem, Paul, MD, PhD

“…Background The effects of primary tumor size on nodal involvement and of number of involved nodes on survival have not, to our knowledge, been examined in a…”
Get full text

Incidence of Basal Cell and Squamous Cell Carcinomas in a Population Younger Than 40 Years by Christenson, Leslie J, Borrowman, Theresa A, Vachon, Celine M, Tollefson, Megha M, Otley, Clark C, Weaver, Amy L, Roenigk, Randall K

“…CONTEXT The incidence of nonmelanoma skin cancer is increasing rapidly among elderly persons, but little is known about its incidence in the population younger…”
Get full text

Leiomyosarcoma of the skin: Clinical, histopathologic, and prognostic factors that influence outcomes by Winchester, Daniel S., MD, Hocker, Thomas L., MD, Brewer, Jerry D., MD, Baum, Christian L., MD, Hochwalt, Philip C., MD, Arpey, Christopher J., MD, Otley, Clark C., MD, Roenigk, Randall K., MD

“…Background Superficial leiomyosarcoma (LMS) is a rare tumor with important clinical, pathologic, and treatment features. Previous LMS studies have included few…”
Get full text

Unknown primary Merkel cell carcinoma: 23 new cases and a review by Tarantola, Tina I., MD, Vallow, Laura A., MD, Halyard, Michele Y., MD, Weenig, Roger H., MD, Warschaw, Karen E., MD, Weaver, Amy L., MSc, Roenigk, Randall K., MD, Brewer, Jerry D., MD, Otley, Clark C., MD

“…Background Knowledge is limited regarding unknown primary Merkel cell carcinoma (UPMCC). Objective We sought to document the characteristics and behavior of…”
Get full text

Melanoma in Solid Organ Transplant Recipients by Zwald, F. O., Christenson, L. J., Billingsley, E. M., Zeitouni, N. C., Ratner, D., Bordeaux, J., Patel, M. J., Brown, M. D., Proby, C. M., Euvrard, S., Otley, C. C., Stasko, T.

“…This manuscript outlines estimated risk and clinical course of pretransplant MM, donor‐transmitted MM and de novo MM posttransplantation and includes an…”
Get full text

Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: A Rochester Epidemiology Project population-based study in Minnesota by Brewer, Jerry D., MD, Shanafelt, Tait D., MD, Khezri, Farzaneh, MD, Sosa Seda, Ivette M., MD, Zubair, Adeel S., BS, Baum, Christian L., MD, Arpey, Christopher J., MD, Cerhan, James R., MD, PhD, Call, Timothy G., MD, Roenigk, Randall K., MD, Smith, Carin Y., BS, Weaver, Amy L., MS, Otley, Clark C., MD

“…Background Cutaneous malignancy is associated with worse outcomes in patients with chronic lymphocytic leukemia (CLL). Objective We sought to identify the…”
Get full text

Opioid prescribing for acute postoperative pain after cutaneous surgery by Lopez, Jonathan J., Warner, Nafisseh S., Arpey, Christopher J., Baum, Christian L., Brewer, Jerry D., Otley, Clark C., Gazelka, Halena M., Roenigk, Randall K.

“…Little information is available to predict which patients require opioid analgesia following cutaneous surgery. When opioids are indicated, information…”
Get full text

Nonneural granular cell tumor treated with Mohs micrographic surgery by Jing, Frank Z., Campbell, Elliott H., Otley, Clark C., Wieland, Carilyn N., Vidal, Nahid Y.

Get full text

Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation by Cook-Norris, Robert H., MD, Michaels, Jason D., MS, Weaver, Amy L., MS, Phillips, P. Kim, MD, Brewer, Jerry D., MD, Roenigk, Randall K., MD, Otley, Clark C., MD

“…Background Most anticoagulants are not associated with increased risk of severe complications during cutaneous surgery, but no data exist on clopidogrel…”
Get full text

Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey by Otley, C.C., Berg, D., Ulrich, C., Stasko, T., Murphy, G.M., Salasche, S.J., Christenson, L.J., Sengelmann, R., Loss JR, G.E., Garces, J.

“…Summary Background  Reduction of immunosuppression is considered a reasonable adjuvant therapeutic strategy in solid‐organ transplant recipients experiencing…”
Get full text

Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation by Kovich, Olympia, Otley, Clark C.

“…Background: Aside from anecdotal reports, there are few data on the risk of thrombotic complications in patients in whom use of warfarin and aspirin is…”
Get full text